OsteoStrand
Device OrthoBiologics
General payments
$339,278
Research payments
$146,338
Through program year 2025, $339,278 in general payments and $146,338 in research payments were reported against OsteoStrand (OrthoBiologics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,292 | 16 |
| 2024 | General | $81,183 | 17 |
| 2023 | General | $117,509 | 33 |
| 2022 | General | $20,866 | 12 |
| 2021 | General | $17,371 | 21 |
| 2021 | Research | $10,165 | 4 |
| 2020 | General | $29,029 | 21 |
| 2020 | Research | $81,444 | 30 |
| 2019 | General | $72,029 | 58 |
| 2019 | Research | $54,729 | 17 |
Breakdown
The top 5 of 12 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
178 general · 51 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.